Aeglea BioTherapeutics
a potential i i indication expansion with dual anti fibrotic and anti inflammatory mechanism a | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
35 of 50
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
September 2023
a potential i i indication expansion with dual anti fibrotic and anti inflammatory mechanism | Aeglea BioTherapeutics
Investor Presentation
July 2023
a potential i i indication expansion with dual anti fibrotic and anti inflammatory mechanism a | Aeglea BioTherapeutics
Related slides by other companies
argenx SE
Results
October 2023
dimensional expansion to reach patients globally indications by | argenx SE
Unilever
Investor Conference
June 2023
future fit portfolio in the us with potential for global expansion hourglass | Unilever
Herbalife
Investor Day
September 2021
nourishing potential product expansion distributor enabling technology and tools investor day | Herbalife
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io